Association of Sodium-Glucose Transport Protein 2 Inhibitor Use for Type 2 Diabetes and Incidence of Gout in Taiwan

IMPORTANCE: The use of sodium-glucose transport protein 2 (SGLT2) inhibitors is currently a standard intervention in patients with type 2 diabetes (T2DM) and exerts favorable pleiotropic effects to consistently lower blood urate levels. However, to date, no association between SGLT2 inhibitor use an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Mu-Chi, Hung, Peir-Haur, Hsiao, Po-Jen, Wu, Laing-You, Chang, Chao-Hsiang, Wu, Ming-Ju, Shieh, Jeng-Jer, Chung, Chi-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605485/
https://www.ncbi.nlm.nih.gov/pubmed/34797368
http://dx.doi.org/10.1001/jamanetworkopen.2021.35353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605485/
https://www.ncbi.nlm.nih.gov/pubmed/34797368
http://dx.doi.org/10.1001/jamanetworkopen.2021.35353

Ejemplares similares